Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

SQ fights back over downplayed SustaiN trial


For immediate release

3 July 2009

SQ fights back over downplayed SustaiN trial


Summit-Quinphos is fighting back over claims by the NDDT and DairyNZ that its coated urea product SustaiN did not out-perform standard urea in a recent NDDT trial.

Dr Jamie Blennerhassett, SQ's Technical Services Manager, says he is at a loss as to why DairyNZ chose to downplay the positive SustaiN results by averaging across all Agrotain rates.

"The purpose of the trial was after all to test whether there was an extra benefit at 1L/t - the commercial rate used by SQ to manufacture SustaiN, compared to other Agrotain rates.

"It isn't a surprise to see that there was less benefit at application rates other than 1 L/t - this is exactly what we told them before the trial. But it is amazing to read DairyNZ downplaying this by saying the best performed Agrotain treatment (SustaiN) in the trial 'produced only an extra 240 kg/DM'.

"That's a great response, which when converted into milk solids could deliver a net benefit from SustaiN of more than $50/ha compared to standard urea. That's what farmers buy SustaiN for - to boost pasture yield and convert that into saleable product."

Dr Blennerhassett says DairyNZ downplayed the benefits of SustaiN by choosing to average across all Agrotain application rates, even though SQ told them beforehand that 1L/t was the SustaiN manufacture rate and the rate they should be focusing on.

"SQ has never made claims for other rates of Agrotain addition. SustaiN is made at 1 L/t and the results at 1 L/t in this trial are in line with what has been found in other trials and show a significant financial benefit from using SustaiN."

ENDS

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.